276 related articles for article (PubMed ID: 10578516)
1. Recombinant human bone morphogenetic protein-2 binding and incorporation in PLGA microsphere delivery systems.
Schrier JA; DeLuca PP
Pharm Dev Technol; 1999; 4(4):611-21. PubMed ID: 10578516
[TBL] [Abstract][Full Text] [Related]
2. Porous bone morphogenetic protein-2 microspheres: polymer binding and in vitro release.
Schrier JA; DeLuca PP
AAPS PharmSciTech; 2001 Oct; 2(3):E17. PubMed ID: 14727876
[TBL] [Abstract][Full Text] [Related]
3. Interaction of recombinant human bone morphogenetic protein-2 with poly(d,l lactide-co-glycolide) microspheres.
Duggirala SS; Mehta RC; DeLuca PP
Pharm Dev Technol; 1996 Apr; 1(1):11-9. PubMed ID: 9552326
[TBL] [Abstract][Full Text] [Related]
4. Effect of a freeze-dried CMC/PLGA microsphere matrix of rhBMP-2 on bone healing.
Schrier JA; Fink BF; Rodgers JB; Vasconez HC; DeLuca PP
AAPS PharmSciTech; 2001 Oct; 2(3):E18. PubMed ID: 14727877
[TBL] [Abstract][Full Text] [Related]
5. Potential of porous poly-D,L-lactide-co-glycolide particles as a carrier for recombinant human bone morphogenetic protein-2 during osteoinduction in vivo.
Boyan BD; Lohmann CH; Somers A; Niederauer GG; Wozney JM; Dean DD; Carnes DL; Schwartz Z
J Biomed Mater Res; 1999 Jul; 46(1):51-9. PubMed ID: 10357135
[TBL] [Abstract][Full Text] [Related]
6. Preparation and property of a novel bone graft composite consisting of rhBMP-2 loaded PLGA microspheres and calcium phosphate cement.
Fei Z; Hu Y; Wu D; Wu H; Lu R; Bai J; Song H
J Mater Sci Mater Med; 2008 Mar; 19(3):1109-16. PubMed ID: 17701313
[TBL] [Abstract][Full Text] [Related]
7. Targeted delivery system for juxtacrine signaling growth factor based on rhBMP-2-mediated carrier-protein conjugation.
Liu HW; Chen CH; Tsai CL; Hsiue GH
Bone; 2006 Oct; 39(4):825-36. PubMed ID: 16782421
[TBL] [Abstract][Full Text] [Related]
8. Bone regeneration produced in rat femur defects by polymer capsules containing recombinant human bone morphogenetic protein-2.
Isobe M; Yamazaki Y; Mori M; Amagasa T
J Oral Maxillofac Surg; 1999 Jun; 57(6):695-8; discussion 699. PubMed ID: 10368095
[TBL] [Abstract][Full Text] [Related]
9. The evaluation of lyophilized polymer matrices for administering recombinant human bone morphogenetic protein-2.
Duggirala SS; Rodgers JB; DeLuca PP
Pharm Dev Technol; 1996 Jul; 1(2):165-74. PubMed ID: 9552343
[TBL] [Abstract][Full Text] [Related]
10. rhBMP-2 release from injectable poly(DL-lactic-co-glycolic acid)/calcium-phosphate cement composites.
Ruhe PQ; Hedberg EL; Padron NT; Spauwen PH; Jansen JA; Mikos AG
J Bone Joint Surg Am; 2003; 85-A Suppl 3():75-81. PubMed ID: 12925613
[TBL] [Abstract][Full Text] [Related]
11. Tetracycline-HCl-loaded poly(DL-lactide-co-glycolide) microspheres prepared by a spray drying technique: influence of gamma-irradiation on radical formation and polymer degradation.
Bittner B; Mäder K; Kroll C; Borchert HH; Kissel T
J Control Release; 1999 May; 59(1):23-32. PubMed ID: 10210719
[TBL] [Abstract][Full Text] [Related]
12. Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo.
Ruhé PQ; Boerman OC; Russel FG; Spauwen PH; Mikos AG; Jansen JA
J Control Release; 2005 Aug; 106(1-2):162-71. PubMed ID: 15972241
[TBL] [Abstract][Full Text] [Related]
13. Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA.
Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP
J Control Release; 1999 Aug; 60(2-3):279-86. PubMed ID: 10425333
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microsphere characteristics.
Bittner B; Morlock M; Koll H; Winter G; Kissel T
Eur J Pharm Biopharm; 1998 May; 45(3):295-305. PubMed ID: 9653634
[TBL] [Abstract][Full Text] [Related]
15. RhBMP-2-loaded Poly(lactic-co-glycolic acid) microspheres fabricated by coaxial electrospraying for protein delivery.
Zhang M; Ma Y; Li R; Zeng J; Li Z; Tang Y; Sun D
J Biomater Sci Polym Ed; 2017 Dec; 28(18):2205-2219. PubMed ID: 28988518
[TBL] [Abstract][Full Text] [Related]
16. Different ratios of lactide and glycolide in PLGA affect the surface property and protein delivery characteristics of the PLGA microspheres with hydrophobic additives.
Chung TW; Tsai YL; Hsieh JH; Tsai WJ
J Microencapsul; 2006 Feb; 23(1):15-27. PubMed ID: 16830974
[TBL] [Abstract][Full Text] [Related]
17. Modulation of anabolic and catabolic responses via a porous polymer scaffold manufactured using thermally induced phase separation.
Yu NY; Schindeler A; Peacock L; Mikulec K; Fitzpatrick J; Ruys AJ; Cooper-White JJ; Little DG
Eur Cell Mater; 2013 Feb; 25():190-203. PubMed ID: 23444237
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery.
Woo BH; Jiang G; Jo YW; DeLuca PP
Pharm Res; 2001 Nov; 18(11):1600-6. PubMed ID: 11758769
[TBL] [Abstract][Full Text] [Related]
19. Chitosan/nHAC/PLGA microsphere vehicle for sustained release of rhBMP-2 and its derived synthetic oligopeptide for bone regeneration.
Ji Y; Wang M; Liu W; Chen C; Cui W; Sun T; Feng Q; Guo X
J Biomed Mater Res A; 2017 Jun; 105(6):1593-1606. PubMed ID: 27862940
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
Kwon YM; Kim SW
Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
